RESOLUTE ONYX China Single Arm Study
NCT: NCT03471845 · ACTIVE_NOT_RECRUITING
NCT IDNCT03471845
StatusACTIVE_NOT_RECRUITING
Start Date2018-03-30
Completion2026-08-30
Brief Summary
It is a single arm clinical evaluation of safety and efficacy of the Medtronic Resolute Onyx™ zotarolimus-eluting coronary stent system in subjects who are eligible for percutaneous transluminal coronary angioplasty (PTCA) in de novo lesions amenable to treatment with Resolute Onyx™ Stent System in China.
Frequently Asked Questions
What is RESOLUTE ONYX China Single Arm Study?
RESOLUTE ONYX China Single Arm Study is a clinical trial registered under NCT03471845. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT03471845?
The current status of NCT03471845 (RESOLUTE ONYX China Single Arm Study) is: ACTIVE_NOT_RECRUITING.
When did RESOLUTE ONYX China Single Arm Study start?
RESOLUTE ONYX China Single Arm Study started on 2018-03-30.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.